Skip to main content
. Author manuscript; available in PMC: 2014 Sep 13.
Published in final edited form as: Cochrane Database Syst Rev. 2010 Apr 14;(4):CD008041. doi: 10.1002/14651858.CD008041.pub2

Comparison 4.

Aspirin 900 mg plus metoclopramide 10 mg versus active comparator

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Headache relief at 2 hours 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
 1.1 Sumartiptan 100 mg 2 523 Risk Ratio (M-H, Fixed, 95% CI) 0.93 [0.79, 1.10]
2 Pain free at 2 hours 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
 2.1 Sumatriptan 100 mg 2 528 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.45, 0.87]
3 Relief of associated symptoms at 2 hours 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
 3.1 Nausea 2 410 Risk Ratio (M-H, Fixed, 95% CI) 1.10 [0.83, 1.46]
 3.2 Vomiting 2 67 Risk Ratio (M-H, Fixed, 95% CI) 10.59 [1.43, 78.64]
4 Persistence of associated symptoms after 2 hours 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
 4.1 Nausea 2 612 Risk Ratio (M-H, Fixed, 95% CI) 0.99 [0.83, 1.19]
 4.2 Vomiting 2 608 Risk Ratio (M-H, Fixed, 95% CI) 0.63 [0.39, 1.02]